Damora Therapeutics Inc (NAS:DMRA)
$ 31.39 +1.2299 (+4.07%) Market Cap: 1.93 Bil Enterprise Value: 2.10 Bil PE Ratio: 0 PB Ratio: 5.00 GF Score: 28/100

Damora Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 17, 2026 / 01:00PM GMT
Release Date Price: $21.42 (+4.03%)
Operator

Welcome to the Damora Therapeutics 2026 Annual Meeting of Stockholders. (Operator Instructions) I will now turn the meeting over to Jennifer Jarrett, Chief Executive Officer and Member of the Board of Damora.

Jennifer Jarrett
Damora Therapeutics Inc - Chief Executive Officer and Member of the Board

Good morning. I'm Jennifer Garrett, Chief Executive Officer and Member of the Board of Damora. On behalf of our entire Board and management team, it is my pleasure to welcome all of you. It is just past for 9:00 AM Eastern Time and a call to order the Damora Annual Stockholders Meeting. Joining me on the call are Garrett Winslow, our General Counsel and Corporate Secretary. Mr. Winslow will serve as a Secretary for this meeting. A representative of our external auditor, [Juan Simeon], is also available for questions.

(Event Instructions) We will now proceed with the formal business of the meeting as set forth in the meeting notice.

By entering the virtual meeting, you should have access to the agenda and rules of conduct, which will govern this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot